Xolair Approved by FDA as First Treatment for Multiple Food Allergies in Adult, Pediatric Patients

Novartis’ and Roche’s Xolair (omalizumab) is indicated to treat severe allergic reactions after accidental exposure to one or more foods in individuals aged one year and above.